Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 131 Total
EDBL - Edible Garden AG Inc - Stock Price Chart
TickerEDBL [NASD]
CompanyEdible Garden AG Inc
CountryUSA
IndustryFarm Products
Market Cap1.65MEPS (ttm)-77.72
P/E-EPS this Y69.16%
Forward P/E-EPS next Y49.47%
PEG-EPS past 5Y32.73%
P/S0.12EPS next 5Y-
P/B-EPS Q/Q91.17%
Dividend-Sales Q/Q32.77%
Insider Own12.96%Inst Own2.80%
Insider Trans0.00%Inst Trans-
Short Float18.80%EarningsApr 01/b
Analyst Recom1.00Target Price40.00
Avg Volume562.64K52W Range3.62 - 89.60
Edible Garden AG, Inc. is a controlled environment agriculture (CEA) farming company, which engages in the usage of traditional agricultural growing techniques together with technology to grow organic food. Its products include lettuces, potted herbs, and cut herbs. The company was founded by James E. Kras and Michael C. James on March 28, 2020 and is headquartered in Belvidere, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DonAroma PamelaDirectorJun 02 '23Buy1.511,0001,5101,000Jun 06 04:30 PM
Kras James E.President and CEOMay 18 '23Buy1.681,0001,67847,265May 19 05:10 PM
PTIX - Protagenic Therapeutics Inc - Stock Price Chart
TickerPTIX [NASD]
CompanyProtagenic Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap6.15MEPS (ttm)-1.15
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-2.91%
P/S-EPS next 5Y-
P/B1.67EPS Q/Q-175.07%
Dividend-Sales Q/Q-
Insider Own19.99%Inst Own7.96%
Insider Trans0.00%Inst Trans-1.82%
Short Float0.28%EarningsApr 01/a
Analyst Recom1.00Target Price16.00
Avg Volume11.86K52W Range0.68 - 2.32
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Arrow Alexander K.Chief Financial OfficerOct 12 '23Buy0.818,0006,48045,815Oct 13 12:48 PM
FLGC - Flora Growth Corp - Stock Price Chart
TickerFLGC [NASD]
CompanyFlora Growth Corp
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap14.52MEPS (ttm)-7.77
P/E-EPS this Y92.06%
Forward P/E-EPS next Y60.17%
PEG-EPS past 5Y-83.38%
P/S0.19EPS next 5Y-
P/B1.90EPS Q/Q68.27%
Dividend-Sales Q/Q56.45%
Insider Own27.64%Inst Own10.54%
Insider Trans21.70%Inst Trans10.85%
Short Float7.33%EarningsMar 28/a
Analyst Recom1.00Target Price6.00
Avg Volume765.62K52W Range0.63 - 5.48
Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis, Over-the-Counter Medical Products and Medical Cannabis Products, Wellbeing Products, and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Starke CliffordCEOApr 08 '24Buy1.90526,315999,998565,714Apr 09 02:17 PM
DAIO - Data io Corp. - Stock Price Chart
TickerDAIO [NASD]
CompanyData io Corp.
CountryUSA
IndustryElectronic Components
Market Cap28.32MEPS (ttm)-0.05
P/E-EPS this Y131.43%
Forward P/E10.47EPS next Y185.71%
PEG-EPS past 5Y-22.25%
P/S1.05EPS next 5Y-
P/B1.44EPS Q/Q-951.43%
Dividend-Sales Q/Q-15.65%
Insider Own13.40%Inst Own36.48%
Insider Trans0.00%Inst Trans-4.45%
Short Float0.06%EarningsApr 25/a
Analyst Recom1.00Target Price6.50
Avg Volume16.19K52W Range2.83 - 4.95
Data I/O Corp. engages in the design, manufacture, and sales of programming and security deployment systems and services for electronic device manufacturers. It operates through the following geographical segments: U.S., Europe, and Rest of the World. The company was founded by Grant C. Record and Milt Zeutchel in 1969 and is headquartered in Redmond, WA.
PCSA - Processa Pharmaceuticals Inc - Stock Price Chart
TickerPCSA [NASD]
CompanyProcessa Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap6.15MEPS (ttm)-8.88
P/E-EPS this Y55.79%
Forward P/E-EPS next Y50.52%
PEG-EPS past 5Y9.70%
P/S-EPS next 5Y15.00%
P/B0.55EPS Q/Q88.48%
Dividend-Sales Q/Q-
Insider Own19.97%Inst Own1.96%
Insider Trans12.40%Inst Trans4.99%
Short Float8.28%Earnings-
Analyst Recom1.00Target Price44.00
Avg Volume1.65M52W Range1.40 - 18.00
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Hanover, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Young DavidPres. Research & DevelopmentFeb 07 '24Buy2.4521,00051,52679,387Feb 08 04:30 PM
Young DavidPres. Research & DevelopmentFeb 06 '24Buy2.5320,00050,50458,387Feb 07 04:22 PM
Lin PatrickChief Business - Strategy OffFeb 01 '24Buy2.401,5003,60027,478Feb 01 06:32 PM
Lin PatrickChief Business - Strategy OffJan 31 '24Buy2.372,5005,92525,978Feb 01 06:32 PM
Ng George KChief Executive OfficerJan 30 '24Buy2.7010,00027,00020,000Jan 31 04:37 PM
GTBP - GT Biopharma Inc - Stock Price Chart
TickerGTBP [NASD]
CompanyGT Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap4.62MEPS (ttm)-5.57
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y70.75%
P/S-EPS next 5Y-
P/B0.62EPS Q/Q58.10%
Dividend-Sales Q/Q-
Insider Own10.42%Inst Own92.43%
Insider Trans0.00%Inst Trans-86.24%
Short Float0.26%EarningsNov 01/b
Analyst Recom1.00Target Price150.00
Avg Volume13.66K52W Range3.52 - 16.11
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). Its product, GTB-3550, is initially developed for the treatment of AML and MDS, and other CD33+ hematologic cancers. GT Biopharma has worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology. The company was founded in 1965 and is headquartered in Brisbane, CA.
VNCE - Vince Holding Corp - Stock Price Chart
TickerVNCE [NYSE]
CompanyVince Holding Corp
CountryUSA
IndustryApparel Manufacturing
Market Cap27.88MEPS (ttm)1.52
P/E1.46EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.09EPS next 5Y-11.00%
P/B0.54EPS Q/Q118.50%
Dividend-Sales Q/Q-14.70%
Insider Own73.11%Inst Own16.14%
Insider Trans0.00%Inst Trans-0.11%
Short Float0.69%EarningsApr 30/b
Analyst Recom3.00Target Price14.00
Avg Volume9.11K52W Range1.00 - 6.92
Vince Holding Corp. engages in the manufacture, design, and sale of luxury apparel and accessories. It operates through the following segments: Wholesale, Direct-to-Consumer, and Rebecca Taylor and Parker. The Wholesale segment deals with the sale of products to premier department stores and specialty stores in the U.S. and in selected international markets. The Direct-to-Consumer segment includes retail and outlet stores and its e-commerce business. The company was founded by Rea Laccone and Christopher LaPolice in 2002 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARDY MICHAEL JDirectorSep 14 '23Buy1.921,0001,92062,953Sep 14 05:53 PM
MARDY MICHAEL JDirectorJul 07 '23Buy2.941,0002,94061,953Jul 07 04:05 PM
Schwefel JonathanChief Executive OfficerJun 29 '23Buy2.942,4757,27680,653Jun 29 06:36 PM
MARDY MICHAEL JDirectorJun 28 '23Buy3.045,00015,20060,953Jun 29 06:31 PM
Stefko DavidDirectorJun 23 '23Sale3.373901,314152,019Jun 26 07:06 PM
ABVC - ABVC BioPharma Inc - Stock Price Chart
TickerABVC [NASD]
CompanyABVC BioPharma Inc
CountryUSA
IndustryBiotechnology
Market Cap15.00MEPS (ttm)-2.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y12.78%
P/S99.97EPS next 5Y-
P/B1.28EPS Q/Q73.75%
Dividend-Sales Q/Q-99.63%
Insider Own17.84%Inst Own1.05%
Insider Trans0.00%Inst Trans-81.20%
Short Float6.14%EarningsNov 15/b
Analyst Recom3.00Target Price20.20
Avg Volume1.05M52W Range0.67 - 9.60
Apr-18-24 09:25AM AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share (GlobeNewswire)
Apr-17-24 09:00AM ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M (GlobeNewswire) -8.93%
Apr-10-24 08:30AM ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M (GlobeNewswire)
Mar-26-24 08:30AM ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M (GlobeNewswire) +21.90%
Mar-21-24 08:30AM AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars (GlobeNewswire)
Mar-19-24 08:30AM ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine (GlobeNewswire)
Mar-14-24 09:30AM ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update (GlobeNewswire)
Feb-27-24 08:30AM ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars (GlobeNewswire)
Feb-15-24 08:30AM ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues (GlobeNewswire)
Feb-12-24 08:30AM ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD) (GlobeNewswire)
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
SWVL - Swvl Holdings Corp - Stock Price Chart
TickerSWVL [NASD]
CompanySwvl Holdings Corp
CountryUnited Arab Emirates
IndustrySoftware - Application
Market Cap73.81MEPS (ttm)8.09
P/E1.34EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.80EPS next 5Y-
P/B9.13EPS Q/Q-90760.29%
Dividend-Sales Q/Q-
Insider Own46.03%Inst Own0.63%
Insider Trans0.00%Inst Trans-
Short Float1.83%EarningsDec 27/b
Analyst Recom3.00Target Price37.50
Avg Volume115.25K52W Range0.62 - 21.94
Swvl Holdings Corp. engages in the provision of mass transit and shared mobility solutions. It provides transportation services through contracting with other service providers or transportation operators. The company was founded on February 8, 2017 and is headquartered in Dubai, United Arab Emirates.
ROKU - Roku Inc - Stock Price Chart
TickerROKU [NASD]
CompanyRoku Inc
CountryUSA
IndustryEntertainment
Market Cap8.09BEPS (ttm)-3.99
P/E-EPS this Y63.25%
Forward P/E-EPS next Y39.42%
PEG-EPS past 5Y-126.17%
P/S2.23EPS next 5Y43.00%
P/B3.48EPS Q/Q74.35%
Dividend-Sales Q/Q18.96%
Insider Own12.66%Inst Own76.69%
Insider Trans-1.18%Inst Trans5.00%
Short Float9.23%EarningsApr 25/a
Analyst Recom2.63Target Price78.92
Avg Volume5.75M52W Range51.62 - 108.84
Today 10:00AM Roku Stock Drops After Earnings: An Opportunity? (Motley Fool)
03:07AM Stock Market Sell-Off: 3 Bargain Stocks Worth Buying Now (Motley Fool)
Apr-26-24 08:45PM Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research) -10.28%
06:42PM Analyst Report: Roku, Inc. (Morningstar Research)
12:54PM Why Roku Stock Is Tumbling Today (Motley Fool)
11:01AM Q1 2024 Roku Inc Earnings Call (Thomson Reuters StreetEvents)
10:24AM Roku warns of ad-supported streaming competition, stock slides (Yahoo Finance Video)
07:00AM PCE reading, Microsoft, Alphabet jump on earnings: Yahoo Finance (Yahoo Finance Video)
Apr-25-24 06:41PM Analyst Report: Roku, Inc. (Morningstar Research)
06:11PM 10 Best Streaming Service Stocks To Buy (Insider Monkey)
Roku, Inc. engages in the provision of a streaming platform for television. It operates through the Platform and Devices segments. The Platform segment includes digital advertising and related services including the demand-side platform and content distribution services such as subscription and transaction revenue shares, media and entertainment promotional spending, the sale of premium subscriptions, and the sale of branded channel buttons on remote controls. The Devices segment is involved in the sale of streaming players, audio products, smart home products, and accessories that are sold through retailers and distributors, as well as directly to customers through the company's website. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Banks Matthew C.VP, Corp Controller & CAOApr 01 '24Sale65.2720713,5115,368Apr 03 04:50 PM
Blackburn Jeffrey MDirectorMar 13 '24Buy63.968,000511,6808,000Mar 13 06:48 PM
Collier CharlesPresident, Roku MediaMar 08 '24Sale65.004,182271,8308,474Mar 11 05:41 PM
Collier CharlesPresident, Roku MediaMar 04 '24Sale63.208,365528,66812,656Mar 05 08:39 PM
KAY STEPHEN HSVP General Counsel, SecretaryMar 04 '24Sale63.204,310272,39281,459Mar 05 08:40 PM
1234567891014